Clinical trial NCT01300273 - References

Type 2 Diabetic Nephropathy — Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy

Citation(s)

•   Adey D, Kumar R, McCarthy JT, Nair KS
  Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E219-25.
•   Kasiske BL, Lakatua JD, Ma JZ, Louis TA
  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998 Jun;31(6):954-61.
•   Mahmood J, Khan F, Okada S, Kumagai N, Morioka T, Oite T
  Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis. Kidney Int. 2006 Nov;70(9):1591-8. Epub 2006 Sep 20.
•   Sato N, Komatsu K, Kurumatani H
  Late onset of diabetic nephropathy in spontaneously diabetic GK rats. Am J Nephrol. 2003 Sep-Oct;23(5):334-42. Epub 2003 Aug 13.
•   Verity MA
  Infantile Pompe's disease, lipid storage, and partial carnitine deficiency. Muscle Nerve. 1991 May;14(5):435-40.
•   Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, Szeto CC
  Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol. 2008 Mar;158(3):317-22. doi: 10.1530/EJE-07-0708.
•   Wang G, Lai FM, Lai KB, Chow KM, Li KT, Szeto CC
  Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract. 2007;106(4):c169-79. Epub 2007 Jun 26.
•   Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A
  Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007 May;18(5):1558-65. Epub 2007 Apr 4.

Phase 4 Study of Mechanisms of Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy

Details for clinical trial NCT01300273